IRIS
EMDIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 87.888
EU - Europa 45.515
AS - Asia 41.969
SA - Sud America 9.340
Continente sconosciuto - Info sul continente non disponibili 1.231
AF - Africa 1.068
OC - Oceania 83
Totale 187.094
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 83.240
SG - Singapore 15.127
IT - Italia 11.134
RU - Federazione Russa 10.948
CN - Cina 10.436
GB - Regno Unito 8.523
BR - Brasile 7.232
VN - Vietnam 6.009
CA - Canada 3.188
DE - Germania 3.020
HK - Hong Kong 3.016
BD - Bangladesh 2.746
UA - Ucraina 2.669
FR - Francia 1.635
DK - Danimarca 1.592
SE - Svezia 1.538
FI - Finlandia 1.102
IN - India 963
MX - Messico 776
IE - Irlanda 770
AR - Argentina 719
PL - Polonia 714
NL - Olanda 561
TR - Turchia 511
ID - Indonesia 436
IL - Israele 413
EC - Ecuador 389
ZA - Sudafrica 370
ES - Italia 357
JP - Giappone 343
IQ - Iraq 339
PK - Pakistan 297
CO - Colombia 267
VE - Venezuela 205
AT - Austria 202
MA - Marocco 173
UZ - Uzbekistan 159
CL - Cile 151
EU - Europa 149
AE - Emirati Arabi Uniti 139
CR - Costa Rica 138
LT - Lituania 137
SA - Arabia Saudita 132
PY - Paraguay 129
MY - Malesia 110
JM - Giamaica 109
EG - Egitto 103
PE - Perù 98
PH - Filippine 98
KE - Kenya 91
TN - Tunisia 84
HN - Honduras 77
KR - Corea 77
DZ - Algeria 71
UY - Uruguay 71
JO - Giordania 68
GT - Guatemala 65
CH - Svizzera 63
BO - Bolivia 62
BE - Belgio 61
IR - Iran 60
NP - Nepal 56
SK - Slovacchia (Repubblica Slovacca) 55
AU - Australia 53
AZ - Azerbaigian 49
PT - Portogallo 47
RO - Romania 47
DO - Repubblica Dominicana 43
TT - Trinidad e Tobago 43
NI - Nicaragua 42
KZ - Kazakistan 41
AL - Albania 40
CZ - Repubblica Ceca 40
SV - El Salvador 37
TW - Taiwan 37
TH - Thailandia 36
ET - Etiopia 34
OM - Oman 33
HU - Ungheria 29
KG - Kirghizistan 27
PR - Porto Rico 27
GR - Grecia 26
PA - Panama 25
AM - Armenia 23
LB - Libano 23
BB - Barbados 22
PS - Palestinian Territory 22
RS - Serbia 22
CI - Costa d'Avorio 21
SN - Senegal 21
GE - Georgia 20
KW - Kuwait 19
NO - Norvegia 19
NZ - Nuova Zelanda 19
SI - Slovenia 18
LV - Lettonia 17
MD - Moldavia 17
QA - Qatar 17
BG - Bulgaria 16
BH - Bahrain 16
Totale 185.661
Salva come PNG Salva come JPEG
Città #
Dallas 13.994
Singapore 7.658
San Jose 6.242
Ashburn 5.932
Southend 5.518
Beijing 4.112
Council Bluffs 3.632
Woodbridge 2.878
Hong Kong 2.736
Chandler 2.556
Ann Arbor 2.548
Houston 2.414
Los Angeles 2.389
Moscow 1.995
Fairfield 1.915
Chicago 1.902
San Mateo 1.857
Ho Chi Minh City 1.732
Milan 1.723
Falls Church 1.553
Seattle 1.363
New York 1.348
Dearborn 1.328
Jacksonville 1.226
The Dalles 1.193
Rome 1.175
Wilmington 1.172
Cambridge 1.162
Hanoi 1.086
Santa Clara 1.042
Buffalo 965
Ottawa 961
São Paulo 817
Hefei 806
Lauterbourg 798
Boardman 780
Salt Lake City 768
Phoenix 749
Dublin 741
Portsmouth 685
Stevenage 685
Pisa 674
Warsaw 644
Dong Ket 641
Helsinki 554
Lawrence 527
Brooklyn 492
Orem 445
Beauharnois 444
Tampa 439
Montreal 416
Munich 412
Montréal 406
London 381
Elk Grove Village 371
Tel Aviv 355
Mexico City 352
Florence 349
Toronto 312
Frankfurt am Main 300
Tokyo 293
Atlanta 290
Denver 284
Naples 277
Columbus 272
Chennai 268
Rio de Janeiro 253
San Diego 239
Johannesburg 234
Stockholm 234
Istanbul 231
Amsterdam 226
Poplar 221
Figino 219
Da Nang 211
Nuremberg 210
Turin 200
Haiphong 197
Bologna 195
Boston 181
Miami 180
Sterling 166
Lancaster 162
Redwood City 161
Old Bridge 158
Washington 154
San Francisco 150
Belo Horizonte 146
Brasília 144
Tashkent 144
Manchester 139
Lappeenranta 132
Guangzhou 131
Guayaquil 130
Palermo 122
Biên Hòa 121
Quito 121
Ankara 120
Curitiba 119
Genoa 117
Totale 112.202
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.862
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.727
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.599
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 1.372
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 911
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 751
Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation 642
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 630
A cross-correlational analysis between electroencephalographic and end-tidal carbon dioxide signals: Methodological issues in the presence of missing data and real data results 531
E-Health in Tuscany Inner Areas: The PROXIMITY-CARE Approach 520
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 507
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 507
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 481
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 475
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 466
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. 442
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions 433
A simple echocardiographic score to rule out cardiac amyloidosis 431
A simple echocardiographic score to rule out cardiac amyloidosis 411
Prognostic Significance of Central Apneas Throughout a 24-Hour Period in Patients With Heart Failure 410
b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. 409
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liverdisease. 402
Trastuzumab cardiotoxicity and drug cardioprotection in healthy and cardiac dysfunction mouse models 398
Impaired HDL Cholesterol Function and High Interleukin-1ß Levels Hold Prognostic Value after ST-elevation Myocardial Infarctio 398
An Open System for Managing Long Term ECG Recordings 396
Intelligent data retrieval system as a decision support in cardiology in an Intranet environment 393
Cartella clinica automatizzata per il reparto di cardiologia 388
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 386
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 386
An open computational toolbox to analyze multi- and single-unit sympathetic nerve activity in microneurography 379
Building medical knowledge from real world registries: The case of heart failure 379
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 375
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 370
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 364
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 364
A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure 363
Central sleep apnea and cardiovascular disease state-of-the-art 361
"To Breathe, or Not to Breathe: That Is the Question" in "The Breathless Heart: Apneas in Heart Failure" 361
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 359
[Central apneas and cardiovascular diseases] 357
Adaptive servo-ventilation therapy does not favourably alter sympatho-vagal balance in sleeping patients with systolic heart failure and central apnoeas: Preliminary data 352
A role for gamma-glutamyltransferase in pathogenesis and evolution of cardiovascular diseases. 350
La neuropatia diabetica 349
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 349
Etiology, clinical presentation, and management of left main coronary artery aneurysms 348
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 348
N-terminal fragment of B-type natriuretic peptide predicts coexisting subclinical heart and vessel disease 347
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 346
Prognostic Impact of QRS Axis Deviation in Patients Treated with Cardiac Resynchronization Therapy 346
Abnormal hyperventilation in patients with hepatic cirrhosis: Role of enhanced chemosensitivity to carbon dioxide. 345
Prediction of the chemoreflex gain by common clinical variables in heart failure 345
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 343
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 343
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 342
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 341
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals 339
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 339
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 337
Preliminary usability assessment for a novel robotic interface for remote Doppler-echocardiography 336
Treating chemoreflex in heart failure: modulation or demolition? 335
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 335
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 332
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 332
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 330
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 329
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 327
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 325
Adrenergic activation in heart failure: blockade or rebalance? 324
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 323
Effects of smoking in patients treated with cardiac resynchronization therapy 321
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 320
Eligibility for vericiguat in a real‐world, contemporary heart failure population 320
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 320
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 319
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 319
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea? 318
Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy 318
Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. 317
Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction 317
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 317
[Ten perspectives for research and innovation in cardiac amyloidosis] 315
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 315
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 315
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 314
Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure 314
CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy 314
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 313
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 313
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 313
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 313
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 312
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 312
Biomarcatori di stabilità della placca aterosclerotica (Rassegna) 311
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 311
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 311
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 310
An analysis of fMRI signal during voluntary breath hold and carbon dioxide challenge: physiological correction and modeling issues 310
A matter of sex—persistent predictive value of MECKI score prognostic power in men and women with heart failure and reduced ejection fraction: a multicenter study 308
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 308
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 308
Totale 42.279
Salva come PNG Salva come JPEG
Categoria #
all - tutte 932.904
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 932.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.107 0 0 0 889 180 250 922 1.669 502 941 138 616
2022/20235.887 547 376 172 845 776 931 52 486 1.037 118 330 217
2023/20244.142 345 129 800 249 173 445 352 194 212 202 162 879
2024/202534.849 265 325 1.822 648 1.291 1.781 4.145 7.450 2.628 3.805 6.753 3.936
2025/202686.022 4.277 13.594 10.172 10.737 8.516 5.099 8.838 3.744 5.070 5.490 5.087 5.398
2026/202714.178 2.362 2.871 5.327 3.618 0 0 0 0 0 0 0 0
Totale 187.094